KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Astrana Health (ASTH) Operating Income (2016 - 2025)

Astrana Health (ASTH) has disclosed Operating Income for 16 consecutive years, with $18.4 million as the latest value for Q4 2025.

  • Quarterly Operating Income rose 2454.86% to $18.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $78.5 million through Dec 2025, down 12.11% year-over-year, with the annual reading at $78.5 million for FY2025, 12.12% down from the prior year.
  • Operating Income hit $18.4 million in Q4 2025 for Astrana Health, down from $19.2 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $53.2 million in Q3 2021 to a low of -$3.9 million in Q4 2023.
  • Historically, Operating Income has averaged $22.7 million across 5 years, with a median of $21.4 million in 2021.
  • Biggest five-year swings in Operating Income: crashed 130.76% in 2023 and later skyrocketed 2454.86% in 2025.
  • Year by year, Operating Income stood at $2.2 million in 2021, then skyrocketed by 459.61% to $12.6 million in 2022, then plummeted by 130.76% to -$3.9 million in 2023, then skyrocketed by 118.6% to $720000.0 in 2024, then surged by 2454.86% to $18.4 million in 2025.
  • Business Quant data shows Operating Income for ASTH at $18.4 million in Q4 2025, $19.2 million in Q3 2025, and $20.3 million in Q2 2025.